International life sciences senior executive with 20 years of experience in Big Pharma and biotech, start-ups, investment banking (M&A) and academic research. A long track record in immunotherapy, CAR-T, cell therapies, gene therapies, regenerative medicine and delivering the tremendous potential of these technologies to patients in need.
Venture Partner and Sector Scoping Committee Member at Deep Science Ventures
PhD, Cell & Gene Therapy